ConductScience.org, home
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension
API referenceFor AI assistants

Trial · NCT02867813

Adverse events1,940

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 1,940

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousAnaemia of malignant diseaseBlood and lymphatic system disordersPlacebo in Parent Study02,532
seriousAnaemia of malignant diseaseBlood and lymphatic system disordersEvolocumab in Parent Study12,499
seriousAnaemia vitamin B12 deficiencyBlood and lymphatic system disordersPlacebo in Parent Study02,532
seriousAnaemia vitamin B12 deficiencyBlood and lymphatic system disordersEvolocumab in Parent Study22,499
seriousBlood loss anaemiaBlood and lymphatic system disordersPlacebo in Parent Study52,532
seriousBlood loss anaemiaBlood and lymphatic system disordersEvolocumab in Parent Study82,499
seriousFebrile neutropeniaBlood and lymphatic system disordersPlacebo in Parent Study02,532
seriousFebrile neutropeniaBlood and lymphatic system disordersEvolocumab in Parent Study12,499
seriousHeparin-induced thrombocytopeniaBlood and lymphatic system disordersPlacebo in Parent Study02,532
seriousHeparin-induced thrombocytopeniaBlood and lymphatic system disordersEvolocumab in Parent Study12,499
seriousIron deficiency anaemiaBlood and lymphatic system disordersPlacebo in Parent Study42,532
seriousIron deficiency anaemiaBlood and lymphatic system disordersEvolocumab in Parent Study22,499
seriousLymphadenopathyBlood and lymphatic system disordersPlacebo in Parent Study12,532
seriousLymphadenopathyBlood and lymphatic system disordersEvolocumab in Parent Study02,499
seriousMicrocytic anaemiaBlood and lymphatic system disordersPlacebo in Parent Study22,532
seriousMicrocytic anaemiaBlood and lymphatic system disordersEvolocumab in Parent Study12,499
seriousPancytopeniaBlood and lymphatic system disordersPlacebo in Parent Study12,532
seriousPancytopeniaBlood and lymphatic system disordersEvolocumab in Parent Study02,499
seriousPolycythaemiaBlood and lymphatic system disordersPlacebo in Parent Study12,532
seriousPolycythaemiaBlood and lymphatic system disordersEvolocumab in Parent Study02,499

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02867813/events?page=2

API referenceFor AI assistants